Spire Healthcare Group PLC (LON:SPI) reports interim results on Thursday and investors will be keen to see further signs of growth in the business.
Sally Taylor, analyst at Numis Securities, in a note said: “We continue to expect an acceleration of growth in H2, as the loss of certain local ‘block’ contract annualises, the disposal of St Saviour’s hospital annualises and capex such as St Anthony’s theatre development as well as the April NHS Tariff increase takes full effect.”
“In terms of H1 performance, we have seen strong growth in NHS e-referral volumes until the end of May and expect an insight into PMI trends and continue to expect high single digit growth in Self-pay.”
Revenue growth is anticipated at around 2% for the first half, with Taylor seeing that pick up to 6% in the second.
Taylor also highlighted the potential for insights into plans for the group’s London development as well as other properties, and potentially some commentary regarding the recent consultation paper on NHS tariffs between 2017 and 2019.
Scheduled to report on Thursday
Interims: Allied Minds PLC (LON:ALM), Anglo Pacific Group plc (LON:APF), Boot (Henry) PLC (LON:BHY), Cairn Homes PLC (LON:CRN), CRH PLC (LON:CRH), IFG Group PLC (LON:IFP), John Laing Group PLC (LON:JLG), Macfarlane Group PLC (LON:MACF), Optibiotix Health PLC (LON:OPTI), Phoenix Group Holdings (LON:PHNX), Playtech Ltd (LON:PTEC), Spire Healthcare Group (LON:SPI), STV Group PLC (LON:STVG),